LanZhou Foci Pharmaceutical Co.,Ltd. (SHE:002644)
7.54
-0.22 (-2.84%)
May 21, 2026, 3:04 PM CST
SHE:002644 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 52.49 | 49.21 | 60.07 | 67.19 | 108.65 | 93.26 |
Depreciation & Amortization | 55.23 | 55.23 | 51.3 | 52.49 | 49.94 | 48.56 |
Other Amortization | 3.68 | 3.68 | 4.57 | 5.98 | 3.65 | 0.38 |
Loss (Gain) From Sale of Assets | -7.13 | -7.13 | -0.04 | - | -0 | -27.18 |
Asset Writedown & Restructuring Costs | -0.27 | -0.27 | - | 0 | 0.2 | 0.37 |
Loss (Gain) From Sale of Investments | 13.54 | 13.54 | 7.23 | 4.49 | 1.3 | 0.85 |
Provision & Write-off of Bad Debts | 26.73 | 26.73 | 29.77 | 15.07 | - | - |
Other Operating Activities | 75 | 30.41 | 6.18 | 2.8 | 2.17 | 1.5 |
Change in Accounts Receivable | -86.74 | -86.74 | -62.2 | 59.5 | -189.54 | -66.85 |
Change in Inventory | 48.36 | 48.36 | 30.26 | -7.3 | -76.02 | -0.8 |
Change in Accounts Payable | 55.56 | 55.56 | -79.85 | -134.73 | 163.45 | -49.49 |
Change in Other Net Operating Assets | - | - | - | - | 23.32 | 11.09 |
Operating Cash Flow | 231.83 | 183.95 | 38.98 | 65.71 | 86.61 | 11.85 |
Operating Cash Flow Growth | 266.99% | 371.85% | -40.67% | -24.13% | 630.59% | -81.15% |
Capital Expenditures | -12.49 | -18.55 | -13.29 | -22.47 | -41.53 | -32.81 |
Sale of Property, Plant & Equipment | 0.27 | 0.27 | 0.02 | 0 | 0.04 | 41.3 |
Cash Acquisitions | - | - | - | -15.46 | - | - |
Investment in Securities | -20 | -20 | 0.34 | 2 | -2.13 | 32.48 |
Other Investing Activities | -0.02 | -0.02 | 1.21 | 1.77 | 0.75 | 1.67 |
Investing Cash Flow | -32.24 | -38.3 | -11.72 | -34.16 | -42.87 | 42.65 |
Long-Term Debt Issued | - | 16 | 12 | 25.66 | 2.6 | - |
Total Debt Issued | 14 | 16 | 12 | 25.66 | 2.6 | - |
Long-Term Debt Repaid | - | -24.83 | -25.1 | -21.45 | -28.31 | -35.27 |
Total Debt Repaid | -24.3 | -24.83 | -25.1 | -21.45 | -28.31 | -35.27 |
Net Debt Issued (Repaid) | -10.3 | -8.83 | -13.1 | 4.21 | -25.71 | -35.27 |
Common Dividends Paid | -7.17 | -7.02 | -15.96 | -27.94 | -7.09 | -61.43 |
Other Financing Activities | -0 | -0 | 0.05 | -1.26 | 3.74 | 3.3 |
Financing Cash Flow | -17.48 | -15.85 | -29 | -25 | -29.06 | -93.41 |
Foreign Exchange Rate Adjustments | -0.19 | -0.19 | 0.31 | 0.67 | 0.7 | -0.21 |
Net Cash Flow | 181.92 | 129.61 | -1.43 | 7.23 | 15.38 | -39.11 |
Free Cash Flow | 219.33 | 165.4 | 25.7 | 43.24 | 45.08 | -20.95 |
Free Cash Flow Growth | 397.16% | 543.70% | -40.58% | -4.08% | - | - |
Free Cash Flow Margin | 24.08% | 18.07% | 2.62% | 3.72% | 4.32% | -2.56% |
Free Cash Flow Per Share | 0.43 | 0.32 | 0.05 | 0.09 | 0.09 | -0.04 |
Cash Interest Paid | - | - | - | - | - | 0.95 |
Cash Income Tax Paid | 100.57 | 100.57 | 81.59 | 101.13 | 68.65 | 78.4 |
Levered Free Cash Flow | 215.57 | 146.89 | -9.9 | 60.54 | -23.75 | -41.83 |
Unlevered Free Cash Flow | 216.05 | 147.38 | -9.38 | 61.32 | -22.91 | -41.24 |
Change in Working Capital | 12.56 | 12.56 | -120.1 | -82.3 | -79.31 | -105.88 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.